share_log

4: Statement of changes in beneficial ownership of securities-Officer Shah Vinay

SEC ·  Nov 19 05:05

Summary by Moomoo AI

Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Vinay Shah, the Chief Financial Officer of Adial Pharmaceuticals, Inc. (ADIL), was involved in a transaction on November 16, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a key executive of the company, any trading activity by Shah is closely monitored by investors and could potentially influence the market's perception of the stock.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more